Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical fluticasone for epithelial barrier and inflammation changes in eosinophilic esophagitis
NL-OMON25172Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Feb 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of fluticasone propionate in eosinophilic esophagitis (EoE), sponsored by Amsterdam University Medical Center. Primary endpoints: Tissue impedance, Intercellular spaces and 1 more. Started Feb 2012; status: active, not recruiting.
02
Drugs
fluticasone propionate
03
Conditions
eosinophilic esophagitis (EoE)
Beyond the preview
Go deeper on NL-OMON25172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON25172.